Climb Bio Inc. (CLYM)
CLYM trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$10.31
-4.80% on the day
Market cap
$592.2M
Small cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | CLYM on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2021 |
| SEC CIK | 0001768446 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials
Not reported in SEC XBRL data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-06-12 |
| Latest annual report | 10-K | 2026-03-05 |
| Latest quarterly / interim | 10-Q | 2026-08-06 |
| Latest current report | 8-K | 2026-09-03 |
| Latest proxy | DEFA14A | 2026-04-24 |
Source: SEC EDGAR submissions feed, 317 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -4.5% |
| 1 month | -26.4% |
| 3 months | -18.7% |
| Year to date | +155.8% |
| 1 year | +411.6% |
| From 52-week high | -42.6% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| NVCT | Nuvectis Pharma Inc. | $18.15 | -7.82% | $591.9M |
| IRWD | Ironwood Pharmaceuticals Inc. | $3.59 | -4.52% | $593.2M |
| AQST | Aquestive Therapeutics Inc. | $4.67 | -2.91% | $586.1M |
| CRMD | CorMedix Inc. | $7.39 | -0.94% | $576.0M |
| DSGN | Design Therapeutics Inc. | $9.78 | -10.36% | $612.0M |
| OLMA | Olema Pharmaceuticals Inc. | $7.02 | -4.62% | $614.2M |
| ZVRA | Zevra Therapeutics Inc. | $10.39 | -8.22% | $617.0M |
| WVE | Wave Life Sciences Inc. | $3.14 | -4.27% | $618.7M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier